 - Subjects who have received treatment with any non-marketed drug substance i.e. a drug which has not yet been made available for clinical use following registration within the 4-week period prior to randomisation or longer, if the class of substance required a longer treatment free period as defined in exclusion criterion 1 for biological treatments 